drugset / Trial / NCT00850174
Oxcarbazepine 600 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to evaluate the comparative bioavailability between Oxcarbazepine 600 mg Tablets (test) and Trileptal® 600 mg Tablets (reference) after a single-dose in healthy subjects under fasting conditions.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxcarbazepine | Small molecule | 600 mg | — |
Indications
No indication recorded.